Lantus solostar training pen dog










News

New disposable insulin pens for diabetics to be launched in January 2008
Sanofi-aventis announced today that a new disposable insulin pen, SoloSTARĀ® for use with the 24-hour insulin LANTUSĀ® or/and the rapid-acting insulin APIDRAĀ® will be available in South Africa starting January 2008. SoloSTARĀ® is a new, easy-to-use.

Tech start-up lets you transfer your unused medicine
Everyone has a box of unused medicine in their cabinet," Kane told CNN. "I started to think about [developing] a solution to save money," he says. JokkoSantƩ, the free mobile app Kane launched in Dakar, works by locals bringing in unused medication to a.

Health Canada approves new Lantus ClikSTAR reusable insulin pen
The Lantus SoloSTAR and Apidra SoloSTAR ready-to-use insulin pens were launched to respond to the different lifestyle needs of patients by providing them with an easier way to self-administer their insulin injections. For this reason, SoloSTAR will.

Answers About Type 1 and Exercise
As a result, Iā€™ve invited two experts to answer your questions about Type 1 and exercise ā€“and anything else you might want to know about diabetes. Answering your questions this week will be: Dr. Robin Goland, director of the Naomi Berrie Diabetes.

Update on the latest in business:
Whole Foods has said that it is taking steps to prevent overcharging, including training ... s Lantus, could go on sale in the U.S. late next year. The French drugmaker today settled a lawsuit over patents for Lantus SoloStar, its insulin in a pen-like.

Three generations tackle diabetes together with the newly available Lantus(R) SoloSTAR(TM) pre-filled insulin pen
I was constantly worried about having a low when I was out alone with my dog, and not being able to find a place to sit down quickly enough," says Trudel. "With Lantus SoloSTAR, Jonathan can inject himself, and the pen makes a clicking noise as he dials up.

Sanofi inaugurates Lantus SoloSTAR pen assembly plant in its Beijing facility
Sanofi has inaugurated a new assembling and packaging line to produce its flagship pre-filled insulin injection pen Lantus SoloSTAR at its Beijing plant ... by better understanding the disease, training physicians, and educating patients.

Sanofi's (SNY) Q4 2014 Results - Earnings Call Transcript
Peter will provide more details on the performance of the diabetes business in the different geographies, but the recent good news is that the market share of Lantus ... SoloStar device builds on the great success and acceptance of the SoloStar pen.

Side Effects
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, expect as may be authorized by the applicable terms of use.

SANOFI : Inaugurates LantusĀ® SoloSTARĀ® Pen Assembly Plant in its Beijing Facility
LantusĀ® (insulin glargine) is the most widely used insulin worldwide, backed by 47 million patient- years of experience by type 1 and type 2 diabetes patients. LantusĀ® is prefilled in the award- winning disposable insulin pen SoloSTARĀ® for.